Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism

Cited by (361)

Items 301–361 of 361

1. Distinct Reactivity of Transient Receptor Potential Vanilloid Subtype 1 in a Murine Model of Atopic Dermatitis with Serious Scratching
   Yan Xia, Akane Tanaka, Kumiko Oida, Akira Matsuda, Hyosun Jang, Yosuke Amagai, Saori Ishizaka, Hiroshi Matsuda · 2014 · The Open Allergy Journal
2. The Treatment of Neuropathic Pain with Cannabinoid Based Nanotechnology
   Oliver Linsell · 2013 · Otago University Research Archive (University of Otago)
3. Synthesis of thiadiazole based carbamates as potent endocannabinoid-hydrolyzing enzyme inhibitors
   Yahaya Adams · 2013 · UEF eRepo (University of Eastern Finland)
4. Peripheral Neuroimmune Interactions and Neuropathic Pain
   Halina Machelska · 2014 · Springer eBooks
5. Lipidomics: From establishment to applications in Health Studies
   Kambiz Varmira, Samaneh Moradi, Reza Khodarahmi‬ · 2015 · Journal of Health Research
6. Changes in endocannabinoid signaling contribute to the anti-hyperalgesic effect of URB597 in a murine model of persistent inflammation.
   Amy E. Lindberg · 2011 · University of Minnesota Digital Conservancy (University of Minnesota)
7. Orthosteric and allosteric probes for cannabinoid receptors
   Ritesh B. Tichkule · 2012
8. Philosophy at Virginia Commonwealth University.
   Lamont Booker · 2011
9. Pushing The Boundaries of Bioluminescence Using Synthetic Luciferins: A Dissertation
   David M. Mofford · 2015 · eScholarship@UMassChan
10. The cannabinoid system and its role in nociception
    Massimiliano Beltramo · 2016 · Wiley eBooks
11. Efeito da radiação ultravioleta B no sistema endocanabinóide cutâneo
    Sofia Beatriz Loureiro Marques de Vasconcelos Magina Silva Ramos · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
12. Comparação dos efeitos farmacológicos do canabidiol e seu análogo sintético HU-474
    Nicole Rodrigues da Silva · 2017
13. Metabolism of N ‐Acylethanolamines: To Phase II and Back Again
    Jessica Karlsson, Christopher John Fowler · 2017 · Encyclopedia of Life Sciences
14. Encodage de l'information sensorielle nociceptive par la moelle épinière et son implication dans les douleurs neuropathiques et leur traitement
    Guillaume Lavertu · 2013 · Corpus Université Laval (Université Laval)
15. Role for Endocannabinoids in Spinal Manipulative Therapy Analgesia?
    Stephen M. Onifer, Randall S. Sozio, Cynthia R. Long · 2019 · Evidence-based Complementary and Alternative Medicine
16. Interacción del antihelmíntico triclabendazol, el analgésico URB937 y sus derivados con transportadores de membrana dependientes de ATP = Interaction of the anthelmintic triclabendazole, the analgesic URB937 and their derivatives with ATP-dependent membrane transporters
    Borja Barrera Cuesta · 2014
17. Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels
    Masaomi Takizawa, Dirk P. Cerneus, Ingrid N. Michon, Sanne Rijnders, John Meijer, Akiyoshi Someya, Yuichiro Z. Sato · 2020 · Advances in Therapy
18. SYNERKINE | IL4-10 fusion protein for the treatment of inflammatory diseases
    Christina Louws · 2020
19. Genetic Variation and Sex Mediate Differential Responses to ∆-9-tetrahydrocannabinol among Inbred Mice
    Cory Parks · 2020
20. État de l’art et intérêt des dosages plasmatiques des substances endocannabinoïdes et endocannabinoïdes-like
    Alexandr Gish, Jean‐François Wiart, Élodie Turpin, Delphine Allorge, Jean‐Michel Gaulier · 2021 · Annales de Toxicologie Analytique
21. Role of Cannabinoids in Pain Management
    Ethan B. Russo, Andrea G. Hohmann · 2014 · Springer eBooks
22. Faculty Opinions recommendation of Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity.
    Daniel Gallie · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
23. Design and synthesis of endocannabinoid enzyme inhibitors for ocular indications
    Alan B. Fulp, Sarah Bingham, Bethany Fisler, Felice Kho, Joshua P. Kim, So Jung Kim, Tabitha Martin, Bailey Mims, Kezia Reji Thomas, Grace Roe et al. · 2022 · Bioorganic & Medicinal Chemistry Letters
24. Perspectives on Neuroscience and Behavior
    2011 · The Neuroscientist
25. Endocannabinoide
    Beat Lutz · 2011 · Springer eBooks
26. Anandamide
    Katrin Legg · 2012 · Lipidomics Gateway
27. Faculty Opinions recommendation of Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier.
    David P. Finn · 2013 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
28. Genetic pain loss disorders
    2022 · Nature Reviews Disease Primers
29. Alteration of the DSI of CA1 pyramidal neurons at the presence of pilocarpine and on the lithium-pilocarpine model of epilepsy
    Marzieh Moradi · 2023
30. A UHPLC–MS/MS method for determination of N-acylethanolamines in cerebrospinal fluid
    Visolakhon Ismoilova, Asger Wretlind, Kourosh Hooshmand, Anja Hviid Simonsen, Steen Gregers Hasselbalch, Cristina Legido‐Quigley · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
31. Fatty Acid Amide Hydrolases in Upland Cotton (Gossypium hirsutum L.) and the Legume Model Medicago truncatula
    Omar Paul Arias Gaguancela · 2023
32. The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics
    Marcela Unterspann, Marek Lapka, Chrysostomos Charalambous, Jiří Slíva · 2025 · European Journal of Pharmacology
33. Fatty Acid Pathways Regulate Thermal Nociception in Caenorhabditis elegans
    Marzieh Abdollahi, Francis Beaudry · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
34. Endocannabinoids in pain modulation
    Victoria Chapman, Stephen George Woodhams · 2025 · Handbook of behavioral neuroscience
35. FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
    Nicole Boury‐Esnault, Christian Marschal, Probst, Jean-Michel Korn-, Gilles Barnathan · 2002 · INFM-OAR (INFN Catania)
36. Additional file 1 of Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
    Dongdem, Julius T., Gideon Kofi Helegbe, Opare-Asamoah, Kwame, Cletus Adiyaga Wezena, Augustine Ocloo · 2022 · Figshare
37. Additional file 1 of Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
    Rosaria Greco, Chiara Demartini, Zanaboni, Anna Maria, Miriam Francavilla, Angelo M. Reggiani, Natalia Realini, Rita Scarpelli, Daniele Piomelli, Tassorelli, Cristina · 2022 · Figshare
38. Endocannabinoids, perioperative pain, and acetaminophen in patients undergoing total knee arthroplasty: a prospective cohort study
    Nathan Clendenen, Anna M. Clendenen, Robert L. McClain, Garret Wheeler, Jost Klawitter, Uwe Christians, Steven R. Clendenen, Jelena Klawitter · 2026 · PAIN Reports
39. Application of squalenoylation in chronic pain alleviation
    Alexandre Da Silva · 2023
40. Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin‐based therapies
    Ilaria Serra, Elisa Bisconti, Daniele Vergara, Anna Maria Giudetti, Francesco Vari · 2026 · British Journal of Pharmacology
41. Cannabinoids in peripheral neuropathic pain: Resolving mechanistic mismatch through CB2-oriented phenotype stratification
    Amina M. Bagher · 2026 · European Journal of Pharmacology
42. Cannabinoid receptors
    Royce Copland, Matthew Chung · 2026 · Elsevier eBooks
43. Early and Divergent Lipid Mediator Remodelling in Fast Versus Slow Skeletal Muscles of Female hSOD1 G93A Mice
    Sebastiaan Dalle, Kaat Vanderbeke, Thibaut Burg, Moniek Schouten, Wout Lauriks, Nicole Hersmus, Ludo Van Den Bosch, Katrien Koppo · 2026 · Journal of Cachexia Sarcopenia and Muscle
44. BindingDB Entry 50040637: Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
    BindingDB · 2013 · UC San Diego
45. BindingDB Entry 8240: Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    BindingDB · 2017 · UC San Diego
46. BindingDB Entry 50047424: Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties.
    BindingDB · 2017 · UC San Diego
47. BindingDB Entry 50008334: Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model.
    BindingDB · 2021 · UC San Diego
48. BindingDB Entry 50047197: Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    BindingDB · 2017 · UC San Diego
49. BindingDB Entry 50017249: Design and synthesis of endocannabinoid enzyme inhibitors for ocular indications.
    BindingDB · 2023 · UC San Diego
50. BindingDB Entry 50040134: ß-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.
    BindingDB · 2013 · UC San Diego
51. BindingDB Entry 50023313: Structure-activity relationship studies and pharmacological evaluation of 4-phenylthiazoles as dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    BindingDB · 2026 · UC San Diego
52. BindingDB Entry 50015553: Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    BindingDB · 2023 · UC San Diego
53. BindingDB Entry 50010033: Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain.
    BindingDB · 2021 · UC San Diego
54. BindingDB Entry 50043192: Synthesis and structure-activity relationship studies of O-biphenyl-3-yl carbamates as peripherally restricted fatty acid amide hydrolase inhibitors.
    BindingDB · 2014 · UC San Diego
55. BindingDB Entry 50006534: Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1.
    BindingDB · 2020 · UC San Diego
56. BindingDB Entry 50001937: Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
    BindingDB · 2020 · UC San Diego
57. BindingDB Entry 50011778: A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
    BindingDB · 2022 · UC San Diego
58. BindingDB Entry 50040090: N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships.
    BindingDB · 2013 · UC San Diego
59. BindingDB Entry 50041943: Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.
    BindingDB · 2013 · UC San Diego
60. Targeting the endocannabinoid system to reduce nociception
    Lamont Booker · 2011 · VCU Scholars Compass (Virginia Commonwealth University)
61. Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
    Khasabova, Iryna A., Khasabov, Sergey, Paz, Justin, Harding-Rose, Catherine, Simone, Donald A., Seybold, Virginia S. · 2012 · The Journal of Neuroscience